Morning Briefing
Summaries of health policy coverage from major news organizations
Fake, Poor-Quality Drugs Boosting Malaria Drug Resistance In Southeast Asia, U.S. Experts Say
"Fake or poor quality malaria drugs are boosting resistance in parts of southeast Asia, a problem that is likely to worsen unless tighter regulations are adopted, U.S. experts said Monday" at a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, Agence France-Presse reports. "'Drug resistance to the most effective drug available, artemisinin-based combination therapy, is developing and has been recognized in southeast Asia,'" Regina Rabinovich, director of infectious diseases at the Bill & Melinda Gates Foundation, said, according to the news service.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
